Immunoglobulin deficiency in multiple sclerosis - prevalence and association with disease-modifying therapy and disease course

被引：0

作者：

Zoehner, G. ^{[1
]}

Miclea, A. ^{[1
]}

Salmen, A. ^{[1
]}

Kamber, N. ^{[1
]}

Diem, L. ^{[1
]}

Friedli, C. ^{[1
]}

Bagnoud, M. ^{[1
]}

Ahmadi, F. ^{[1
]}

Briner, M. ^{[1
]}

Sedille-Mostafaie, N. ^{[2
]}

Constantinos, K. ^{[3
]}

Leonidas, S. ^{[3
]}

Chan, A. ^{[1
]}

Hoepner, R. ^{[1
]}

Evangelopoulos, M. E. ^{[3
]}

机构：

[1] Univ Bern, Univ Hosp Bern, Inselspital, Dept Neurol, Bern, Switzerland

[2] Univ Bern, Univ Hosp Bern, Inselspital, Univ Inst Clin Chem, Bern, Switzerland

[3] Univ Athens, Eginit Univ Hosp, Dept Neurol, Athens, Greece

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EPR3107

引用

页码：341 / 341

页数：1

共 50 条

[41] DISEASE-MODIFYING THERAPIES FOR MULTIPLE-SCLEROSIS
CARTER, JL
[J]. CNS DRUGS, 1995, 3 (02) : 99 - 114
[42] Adherence to Disease-Modifying Therapies for Multiple Sclerosis
Higuera, Lucas
Carlin, Caroline S.
Anderson, Sarah
[J]. Journal of Managed Care & Specialty Pharmacy, 2016, 22 (12): : 1394 - 1401
[43] Emerging Disease-Modifying Therapies in Multiple Sclerosis
Jai Perumal
Omar Khan
[J]. Current Treatment Options in Neurology, 2012, 14 : 256 - 263
[44] Disease-Modifying Treatment in Progressive Multiple Sclerosis
Ciotti, John Robert
Cross, Anne Haney
[J]. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2018, 20 (05)
[45] Multiple Sclerosis: Overview of Disease-Modifying Agents
Finkelsztejn, Alessandro
[J]. PERSPECTIVES IN MEDICINAL CHEMISTRY, 2014, 6 : 65 - 72
[46] Update on disease-modifying therapies for multiple sclerosis
Vargas, Diana L.
Tyor, William R.
[J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (05) : 883 - 891
[47] Discontinuing disease-modifying multiple sclerosis therapies
Krysko, Kristen
[J]. LANCET NEUROLOGY, 2023, 22 (07): : 543 - 545
[48] Multiple Sclerosis, Disease-Modifying Therapies, and Infections
Langer-Gould, Annette M.
Smith, Jessica B.
Gonzales, Edlin G.
Piehl, Fredrik
Li, Bonnie H.
[J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (06):
[49] Oral Disease-Modifying Therapies for Multiple Sclerosis
Kim, Woojun
Zandona, Manuella Edler
Kim, Su-Hyun
Kim, Ho Jin
[J]. JOURNAL OF CLINICAL NEUROLOGY, 2015, 11 (01): : 9 - 19
[50] Use of Disease-Modifying Drugs in Multiple Sclerosis
Wurzius, F. Q.
Silva, C. B.
de Vecino, M. A.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 102 - 103

← 1 2 3 4 5 →